Compare CMT & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMT | IPSC |
|---|---|---|
| Founded | 1996 | 2019 |
| Country | United States | United States |
| Employees | 1570 | N/A |
| Industry | Electronic Components | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.4M | 189.7M |
| IPO Year | 1996 | 2021 |
| Metric | CMT | IPSC |
|---|---|---|
| Price | $18.86 | $2.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 16.2K | ★ 976.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.07 |
| EPS | ★ 0.93 | 0.11 |
| Revenue | ★ $284,290,000.00 | $6,589,000.00 |
| Revenue This Year | N/A | $1,590.09 |
| Revenue Next Year | $6.66 | N/A |
| P/E Ratio | $20.89 | ★ $20.64 |
| Revenue Growth | 5.49 | ★ 194.81 |
| 52 Week Low | $12.25 | $0.34 |
| 52 Week High | $22.29 | $2.71 |
| Indicator | CMT | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 40.10 | 62.07 |
| Support Level | $17.81 | $0.49 |
| Resistance Level | $19.58 | $2.71 |
| Average True Range (ATR) | 0.69 | 0.19 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 0.00 | 79.33 |
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.